Manchester research hub appoints industry liaison
August 19, 2009Research and Development Academic, NHS
The Manchester Biomedical Research Centre (BRC) has appointed a new industry-facing executive to forge new research links with the industry.Dr …
Novartis’ Extavia approved in US
August 19, 2009Research and Development, Sales and Marketing Extavia, MS, Novartis
Novartis has received US approval for its betaferon product for multiple sclerosis.Extavia’s active ingredient is interferon beta-1b, putting it into …
US pharma accused of selling out to Obama
August 19, 2009Research and Development, Sales and Marketing US, US healthcare, healthcare, industry
The US industry is accused of selling out to President Obama’s healthcare take-over, with its leaders seeking favourable treatment from …
$2bn deal will create pharma packaging giant
August 19, 2009Manufacturing and Production Amcor, MA
Australian company Amcor looks set to join the healthcare packaging giants via a $2 billion deal to purchase the pharmaceutical, …
Off-label rules for cancer need to be clarified
August 18, 2009Research and Development, Sales and Marketing Cancer, NHS, off label
A new report is pressing for the off label prescribing of drugs to be made clearer and more fair for …
ClinPhone accounts give Parexel a hangover
August 18, 2009Research and Development Clinphone
Accounting errors at recently-acquired ClinPhone pegged back Parexel's operating profits in its latest quarterly reports, and it will be some …
GSK starts first trials for H1N1 vaccine in Germany
August 17, 2009Research and Development, Sales and Marketing GSK, h1n1, vaccines
GSK is to embark on the clinical development for its pandemic swine flu vaccine, completing enrolment into its first study …
Genzyme says Cerezyme shortages could last longer than expected
August 17, 2009Research and Development, Sales and Marketing Gaucher, Genzyme
The shortage of Genzyme's enzyme replacement therapy Cerezyme look set to last longer than expected, as the company has taken …
Vulnerable groups first in line for UK swine flu jabs
August 14, 2009Research and Development, Sales and Marketing NHS, h1n1
The first 11 million people to receive jabs against the H1N1 virus have been announced by the government, ready for …
Pharma manufacturing news in brief
August 14, 2009Manufacturing and Production Mylan
Pharmafocus' round-up of manufacturing news includes an all-clear for Mylan's Morgantown facility, GSK's flu vaccine plans and updates from the …
Twitter campaign to defend the NHS
August 14, 2009Medical Communications, Sales and Marketing NHS, digi
UK politicians have thrown their weight behind a Twitter campaign to defend the reputation of the NHS against increasingly virulent …
Online hospital comparison site launched
August 13, 2009Medical Communications NHS, digi, healthcare
Patients in the UK have been given the chance to rate hospitals by a variety of criteria using a new …
Animal rights attacks were terrorism not activism, says Vasella
August 13, 2009Research and Development, Sales and Marketing Animal tests, Novartis, Vasella
Novartis chief executive Daniel Vasella has spoken for the first time of his shock at the arson attack on his …
Obama hits back at healthcare reform critics
August 13, 2009NHS, Obama, US healthcare, healthcare
President Obama has hit back at critics of his reform plans, saying their campaigns are using scare tactics to keep …
Patheon wins EMEA approval for Puerto Rico plant
August 13, 2009Manufacturing and Production Patheon
Canadian contract manufacturer Patheon has been cleared to import solid-dose products from its plant in Manati, Puerto Rico, into Europe …
AZ signs antibiotic deal with Forest Laboratories
August 13, 2009Research and Development, Sales and Marketing Antibiotics, Forest
AstraZeneca has struck a deal with Forest Laboratories to co-develop and commercialise ceftaroline, an anti-infective drug in phase III. The …
Green manufacturing from the deep blue sea
August 12, 2009Manufacturing and Production Ingenza
UK researchers have embarked on a project to analyse marine microorganisms for enzymes that could be used to manufacture chiral …
Authorised generics deals likely here to stay, says analyst
August 12, 2009Research and Development, Sales and Marketing generics
The practice of branded drugmakers paying rivals to keep generics off the market after product patent expiry – known as …
EMEA makes adverse drug reaction research a priority
August 12, 2009Research and Development, Sales and Marketing Europe, drug safety
Adverse drug reaction in hyperactive children has been made a key research priority for next year by the European Medicines …
New FDA head aims for aggressive enforcement
August 11, 2009Research and Development, Sales and Marketing FDA, US, drug safety
The new head of US regulator the FDA has set out a vision to support public health, through tighter laws …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
